Lanthanum carbonate
Lanthanum carbonate is a pharmaceutical drug with 27 clinical trials. Historical success rate of 91.7%.
Success Metrics
Based on 22 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
4
Mid Stage
13
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
91.7%
22 of 24 finished
8.3%
2 ended early
0
trials recruiting
27
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Healthy Combine Study
Phosphate Lowering in CKD Trial
The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE
Different Effects of Non-calcium Phosphate Binders on Serum Calcium
Long-term Effect of Lanthanum Carbonate on Bone
Clinical Trials (27)
Healthy Combine Study
Phosphate Lowering in CKD Trial
The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE
Different Effects of Non-calcium Phosphate Binders on Serum Calcium
Long-term Effect of Lanthanum Carbonate on Bone
Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease
Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease
Effect of Lanthanum Carbonate in Patients Previously Treated With Calcium-based Phosphate Binder Therapy
A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.
Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteers
A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on Dialysis
Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKD
Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood
Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis
Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease
Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5
Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia
Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis
Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study
Fosrenol and Phosphorus Balance - Lanthanum Carbonate
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 27